Announcements

  • Welcome to the AAPS Formulation & Delivery Community

    Dear Colleagues,

    We are delighted to welcome you to the AAPS Formulation & Delivery Community, established as part of AAPS’ new science‑focused Community structure effective March 25, 2026

    This Community brings together a diverse and global group of scientists working across formulation science, drug delivery technologies, and enabling platforms, spanning early development through commercialization. Our shared mission is to foster scientific excellence, meaningful collaboration, and impactful programming that advances the pharmaceutical sciences and supports the evolving needs of our members.

    The Formulation & Delivery Community builds on the strong foundations and scientific legacies of several former Communities. We are committed to ensuring continuity where it matters, while also creating space for new ideas, cross‑disciplinary engagement, and emerging areas of science.

    As Chair and Vice Chair, we look forward to working with you to shape a vibrant, inclusive, and forward‑looking Community. In the months ahead, we will be engaging members around scientific initiatives, programming opportunities, and avenues for active participation and leadership within AAPS.

    We warmly welcome your ideas, perspectives, and involvement, and we look forward to connecting with you as we collectively build and grow this Community.

    With best regards,

    Sandip Tiwari, PhD
    Chair, Formulation & Delivery Community
    American Association of Pharmaceutical Scientists (AAPS)

    Vivek Gupta, PhD, FAAPS
    Vice Chair, Formulation & Delivery Community
    American Association of Pharmaceutical Scientists (AAPS)

  • Recognize Peer Review Week with AAPS

    AAPS joins STEM organizations from across the breadth of the sciences in recognizing Peer Review Week, September 15-19, 2025. This week-long celebration highlights the value of peer review in ensuring credibility in research and this year's theme is "Rethinking Peer Review in the AI Era."

     

    In recognition of Peer Review Week, AAPS will open the eLearning webinars, “” and “” to non-members for a limited time, along with the opening plenary from the 2025 PharmSci 360. This session featured a (starts at 48:00) with Ivan Oransky, M.D., Co-founder of and Colby Vorland, Ph.D., Assistant Research Scientist at the Indiana University School of Public Health-Bloomington.

     

    Through its four peer-reviewed journals (, , , and ), AAPS supports ethical, credible science with the help of hundreds of scientist-volunteers who share their time and expertise by participating in peer review. Independent peer reviewers for these publications are critical to assuring the quality of scientific research used in the development of products and therapies that improve global health.

  • 🚨FINAL DAY FOR EARLY BIRD PRICING🚨

    Experience cutting-edge scientific content at #PharmSci360, November 9-12, in San Antonio, along with #professionaldevelopment sessions and opportunities at #Careers360 in our Solution Center.

    ⏰ Today is the final day for Early Bird Pricing! Register today and save. ⏰

  • 2025 AAPS Board Election Results Announced

    AAPS is pleased to announce that our members have elected new leaders to the AAPS Board of Directors.

    Congratulations to President-elect @Otilia Koo, PhD, FAAPS, Novo Nordisk, and Members-at-Large @Carl Allenspach, Ph.D., Bristol Myers Squibb and @Kevin Litwiler, Ph.D., OnKure Therapeutics.

  • AAPS Elevates Eight Members to Fellow Status

    👏👏 AAPS is pleased to announce that eight members have been selected for elevation to Fellow status in recognition of their professional excellence and sustained superior impact in fields relevant to AAPS’ mission: advancing the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

    The new Fellows will be formally inducted at #PharmSci360.

    Congratulations to all! 🎉

  • An Exclusive Offer to Attend the Bioprocessing Summit, August 18-21 in Boston

    Join industry experts at the Bioprocessing Summit, taking place August 18-21, 2025, at the Omni Boston Hotel at the Seaport, a new venue in the heart of Boston’s trendy Seaport District.

    Recognized as the premier event for innovation in bioprocess R&D, scale-up, quality, analytics, and the growing role of AI and machine learning, the Summit brings together the brightest minds from pharma, biotech, and academia.

    This year’s program features over 250 expert speakers and cutting-edge sessions that span the full bioprocessing spectrum, offering opportunities to connect, collaborate, and advance strategy from early discovery to commercial manufacturing.

    Explore the sessions, training seminars, and networking opportunities, plan your experience, and see how you can get involved at BioprocessingSummit.com.

  • 🗳️ Last Chance! Cast Your Vote in the AAPS Board Election! 🗳️

    The AAPS election is open through tomorrow. Cast your vote for the future president and members-at-large of the AAPS Board of Directors.
    Elected members of the Board of Directors fulfill AAPS' mission to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.
     
    Every vote makes a difference.
     
  • Two AAPS Journals See Increase in Impact Factors

    👏 AAPS is pleased to announce that the impact factors for the peer-reviewed journals AAPS PharmSciTech and Pharmaceutical Research increased in 2024. 👏

    📚 AAPS members have free, unlimited, electronic access to articles in AAPS’ four peer-reviewed #journals.

  • Discover "Bioequivalence Requirements in Various Global Jurisdictions"

    AAPS fosters the science you practice by advancing scientific discovery, exchange, and learning. AAPS members receive a discount on AAPS books. 📚

    Don't miss "Bioequivalence Requirements in Various Global Jurisdictions", a part of the AAPS Advances in the Pharmaceutical Sciences Series, from editor Isadore Kanfer. This book 📖 :

    📗 Combines BE, bioequivalence, standards from across the world into a single reference source-harmonize standards
    📘 Provides updated information on regulatory guidances for the market approval of generic products
    📙 Describes and explains the various procedures, protocols, and statistical requirements for bioequivalence studies

  • The AAPS Election is Open — Vote Now!

    Vote for 2026 AAPS Board Members

    The AAPS election is . Cast your vote for the future president and members-at-large of the AAPS Board of Directors.

     

    Elected members of the Board of Directors fulfill AAPS' mission to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

     

    Every vote makes a difference.

     

    You will need your member identification number to vote.

     

    by July 31, 2025 at 5pm ET.

    Meet the Candidates

    President-elect

    Regeneron Pharmaceutics, Inc.

    Novo Nordisk

    Members-at-Large

    Bristol Myers Squibb

    University of Alabama at Birmingham

    Onkure Inc.

    Passage Bio

  • Inside AAPS NBC with AAPS President Dr. Russ Weiner

    Tune in 🔊 to the latest BioTalk Unzipped podcast episode, filmed live during the NBC2025 in Boston, that features AAPS President @Russell Weiner.

  • Join AAPS Next Month

    The landscape of GLP-1 therapeutics is rapidly evolving. Staying ahead of the curve is crucial for research teams. 🌐
    Join AAPS on May 13-14, for Beyond GLP-1s: Where the Science Will Take Business Next. This workshop brings business leaders and scientists together to explore the latest innovations in the field and how science is driving the future of diabetes therapeutics. 💡
    With discounted pricing for AAPS members and a great lineup of speakers, this is an opportunity you won’t want to miss!

  • Submit Your 2025 PharmSci 360 Proposals!

    See the latest science and make new connections this November. AAPS just opened registration for the 2025 #PharmSci360 in San Antonio, TX, November 9-12! Register today!

    This is your final opportunity to submit a session proposal for the 2025 PharmSci 360. The submission deadline is today, April 8, at 5 PM ET.